invest summari recent publish model post
earn releas today made minor adjust financi model
bring in-lin public comment made earn call
lower revenu ep estim modestli
 valuat use blend dcf multipl ev/ebitda analysi get
price target
disclosur section may found page
arriv price target merck share use blend dcf
competit setback key product could materi neg impact
merck abil gener profit oper cash flow depend larg continu
profit compani key product januvia janumet keytruda gardasil/
gardasil isentress result compani depend key product event
advers affect product market product could
signific advers impact result oper cash flow event could
includ loss patent protect increas cost associ manufactur gener
over-the-count avail compani product competit product discoveri
previous unknown side effect result post-approv trial increas competit
introduct new more-effect treatment discontinu remov
market product reason event could materi advers effect
sale product
merck effort may succeed develop commerci success product
like major pharmaceut compani order remain competit merck must
continu launch new product year expect declin sale product
loss market exclus mean compani futur success depend pipelin
new product includ new product may develop collabor joint
ventur product abl obtain licens acquisit accomplish
compani commit substanti effort fund resourc research develop
dedic resourc variou collabor third parti
high rate failur inher research develop process new drug
result high risk fund invest merck research program
gener financi return risk profil compound fact research
long invest cycl bring pharmaceut compound discoveri phase
market may take decad failur occur point process includ
later process signific fund invest
merck could continu face price pressur respect product merck
could continu face price pressur global particularli matur market
manag care organ govern agenc program could neg affect
compani sale profit margin unit state includ practic manag
care group institut government purchas feder law regul
relat medicar medicaid includ medicar prescript drug improv
modern act state activ aim increas price
transpar chang healthcar system enact part healthcar reform
unit state well increas purchas power entiti negoti behalf
medicar medicaid privat sector beneficiari could result price pressur
addit larger custom may futur ask receiv higher rebat
drug certain highli competit categori compani must also compet place
formulari manag care organ exclus product formulari
lead reduc usag manag care organ
exhibit incom statement analysi
exhibit margin analysi
exhibit quarterli sale analysi
exhibit annual sale analysi
exhibit analysi
exhibit balanc sheet analysi
merck co inc global healthcar compani deliv innov health solut prescript medicin vaccin
biolog therapi anim health product compani oper includ four oper segment anim health
allianc segment segment includ human health pharmaceut vaccin product
health pharmaceut product consist therapeut prevent agent gener sold prescript treatment
human disord anim health segment discov develop manufactur market anim health product includ vaccin
compani segment provid servic solut focu engag health analyt clinic servic
improv valu care deliv patient compani incorpor new jersey
analyst primarili respons research report whose name appear front cover certifi view express
research report accur reflect person view subject secur issuer featur report ii part
research analyst compens directli indirectli relat specif recommend view express
research analyst report
